Bladder cancer treatment by using e09 and propylene glycol

Details Bladder cancer treatment by using e09 and propylene glycol Bladder cancer treatment by using e09 and propylene glycol

A - Human Necessities

61

K

A61K 31/404 (2006.01) A61K 47/10 (2006.01)

Patent

CA 2638026

Disclosed herein are various bladder cancer treatments and methods. The present disclosure can take advantage of propylene glycol concentrations and/or NAD(P)H:quinone oxidoreductase-1 (NQO1 ), Cytochrome P450 Oxidoreductase (P450R) and Glucose transporter 1 (Glut-1 ) protein expression in human transitional cell carcinoma of the bladder to offer individually targeted bladder cancer treatments.

La présente invention concerne divers traitements et procédés du cancer de la vessie. La présente invention utilise des concentrations de propylène glycol et/ou de l'expression de NAD(P)H quinone oxydoréductase-1 (NQO1 ), cytochrome P450 oxydoréductase (P45OR) et de la protéine de transport du glucose1 (Glut-1 ) dans le carcinome cellulaire de transition de la vessie humaine pour fournir des traitement du cancer de la vessie à ciblage individuel.

Affiliated with

Also associated with

Rating

Bladder cancer treatment by using e09 and propylene glycol does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bladder cancer treatment by using e09 and propylene glycol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bladder cancer treatment by using e09 and propylene glycol will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1752072